Medpace
MEDP
592 hedge funds and large institutions have $10.2B invested in Medpace in 2024 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 182 increasing their positions, 245 reducing their positions, and 42 closing their positions.
121% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 42
62% more call options, than puts
Call options by funds: $83M | Put options by funds: $51.1M
33% more capital inflows, than outflows
Capital inflows: $968M | Capital outflows: $730M
9% more funds holding
Funds holding: 543 → 592 (+49)
1.97% more ownership
Funds ownership: 80.24% → 82.21% (+2%)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
26% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 245
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Findlay Park Partners
London,
United Kingdom
|
+$78.5M |
| 2 |
ClearBridge Investments
New York
|
+$68.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$59.3M |
| 4 |
Goldman Sachs
New York
|
+$55.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$49.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Trust Walden
Boston,
Massachusetts
|
-$77.8M |
| 2 |
Wasatch Advisors
Salt Lake City,
Utah
|
-$74.5M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$44.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$35M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$34M |
MEDP Hedge Fund Activity: Q1 2024 in Review
592 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2024, worth a combined $10.2B — up 35% from $7.55B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new MEDP positions and 42 closed out — a net gain of 51 holders — while 182 added to existing stakes and 245 trimmed.
The largest buyer was Findlay Park Partners, opening a new position worth an estimated $78.5M. The largest seller was Boston Trust Walden, cutting an estimated $77.8M.
- 592 institutional investors held Medpace (MEDP) as of Q1 2024, up from 543 in Q4 2023.
- Funds reported $10.2B of Medpace stock for Q1 2024, up 35% quarter-over-quarter.
- 93 funds opened new Medpace positions in Q1 2024 and 42 closed out, a net change of +51 holders.
- The largest Medpace buyer in Q1 2024 was Findlay Park Partners, an estimated $78.5M added.
- The largest Medpace seller in Q1 2024 was Boston Trust Walden, an estimated $77.8M sold.
Based on aggregated 13F filings for Q1 2024.